Sponsor:
GlaxoSmithKline
Code:
NCT06920043
Conditions
Metabolic Dysfunction-Associated Steatohepatitis
Non-alcoholic Fatty Liver Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Efimosfermin
Placebo
Brief summary:
Conditions
Metabolic Dysfunction-Associated Steatohepatitis
Non-alcoholic Fatty Liver Disease
Study ID
NCT06920043
Start date
Apr 9, 2025
Status verified date
Jul, 2026
Completion date
Jul 10, 2028
Anticipated
Primary completion date
Jul 10, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
42 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Efimosfermin (Dose 1)
experimental: Efimosfermin (Dose 2)
placebo comparator: Placebo
Interventions
Efimosfermin
Placebo
Primary outcome measure
Central contacts
Locations
GSK Investigational Site
Recruiting
Chandler, Arizona, United States, 85224
Contacts
Principal Investigator:
Anita Kohli
GSK Investigational Site
Recruiting
Mesa, Arizona, United States, 85381
Contacts
Principal Investigator:
Ann Moore
GSK Investigational Site
Recruiting
Tucson, Arizona, United States, 85712
Contacts
Principal Investigator:
Aimee Bachelier
GSK Investigational Site
Recruiting
Fresno, California, United States, 93720
Contacts
Principal Investigator:
Muhammad Sheikh
GSK Investigational Site
Recruiting
Lancaster, California, United States, 93534
Contacts
Principal Investigator:
Jatinder Pruthi
GSK Investigational Site
Recruiting
Pasadena, California, United States, 91105
Contacts
Principal Investigator:
Edward Mena
GSK Investigational Site
Recruiting
Rialto, California, United States, 92377
Contacts
Principal Investigator:
Zeid Kayali
GSK Investigational Site
Recruiting
Santa Maria, California, United States, 93458
Contacts
Principal Investigator:
Keval Shah
GSK Investigational Site
Recruiting
Miami, Florida, United States, 33156
Contacts
Principal Investigator:
Lazaro M Garcia
GSK Investigational Site
Recruiting
Viera, Florida, United States, 32940
Contacts
Principal Investigator:
Rosemary Laird
GSK Investigational Site
Recruiting
Marietta, Georgia, United States, 30060
Contacts
Principal Investigator:
Aasim Sheikh
GSK Investigational Site
Recruiting
Baltimore, Maryland, United States, 21202
Contacts
Principal Investigator:
Paul Thuluvath
GSK Investigational Site
Recruiting
Kansas City, Missouri, United States, 64131
Contacts
Principal Investigator:
Bradley Freilich
GSK Investigational Site
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Frances Lee
GSK Investigational Site
Recruiting
Fayetteville, North Carolina, United States, 28304
Contacts
Principal Investigator:
John Poulos
GSK Investigational Site
Recruiting
Wilson, North Carolina, United States, 27612
Contacts
Principal Investigator:
Mitchell Mahmoud
GSK Investigational Site
Recruiting
Austin, Texas, United States, 78745
Contacts
Principal Investigator:
Nomita Kim
GSK Investigational Site
Recruiting
Austin, Texas, United States, 78757
Contacts
Principal Investigator:
Rohit Puskoor
GSK Investigational Site
Recruiting
Austin, Texas, United States, 78757
Contacts
Principal Investigator:
Carmen Landaverde
GSK Investigational Site
Recruiting
Dallas, Texas, United States, 75203
Contacts
Principal Investigator:
Parvez Mantry
GSK Investigational Site
Recruiting
Georgetown, Texas, United States, 78626
Contacts
Principal Investigator:
Nirupama Jerome
GSK Investigational Site
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Prasun Jalal
GSK Investigational Site
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Joseph Galati
GSK Investigational Site
Recruiting
Houston, Texas, United States, 77079
Contacts
Principal Investigator:
David Huang
GSK Investigational Site
Recruiting
Pasadena, Texas, United States, 77505
Contacts
Principal Investigator:
Rukan Daccak
GSK Investigational Site
Recruiting
Pearland, Texas, United States, 77584
Contacts
Principal Investigator:
Jignesh Shah
GSK Investigational Site
Recruiting
San Antonio, Texas, United States, 78215
Contacts
Principal Investigator:
Eric Lawitz
GSK Investigational Site
Recruiting
San Antonio, Texas, United States, 78229
Contacts
Principal Investigator:
Daniel Santillano
GSK Investigational Site
Recruiting
Waco, Texas, United States, 76710
Contacts
Principal Investigator:
Gregg Lucksinger
GSK Investigational Site
Recruiting
Richmond, Virginia, United States, 23249
Contacts
Principal Investigator:
Michael Fuchs
Sponsor
GlaxoSmithKline
Last update posted
Jul 8, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2026-07-08.